Werner Siegmund

7.9k total citations
185 papers, 6.3k citations indexed

About

Werner Siegmund is a scholar working on Oncology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Werner Siegmund has authored 185 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Oncology, 50 papers in Pharmacology and 43 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Werner Siegmund's work include Drug Transport and Resistance Mechanisms (75 papers), Pharmacogenetics and Drug Metabolism (40 papers) and Pharmacological Effects and Toxicity Studies (31 papers). Werner Siegmund is often cited by papers focused on Drug Transport and Resistance Mechanisms (75 papers), Pharmacogenetics and Drug Metabolism (40 papers) and Pharmacological Effects and Toxicity Studies (31 papers). Werner Siegmund collaborates with scholars based in Germany, United States and Switzerland. Werner Siegmund's co-authors include Stefan Oswald, Werner Weitschies, Heyo K. Kroemer, Thomas Gießmann, Ingolf Cascorbi, R Warzok, Markus Keiser, Markus Grube, Norbert Hosten and Hubert Mönnikes and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and NeuroImage.

In The Last Decade

Werner Siegmund

181 papers receiving 6.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Werner Siegmund Germany 42 2.7k 1.5k 1.1k 1.0k 910 185 6.3k
Pieter Annaert Belgium 49 1.9k 0.7× 1.4k 0.9× 1.3k 1.3× 1.2k 1.2× 1.9k 2.1× 237 7.6k
Yusuke Tanigawara Japan 40 3.9k 1.4× 1.9k 1.2× 2.1k 2.0× 1.5k 1.4× 589 0.6× 177 8.8k
Toshiyuki Sakaeda Japan 45 2.8k 1.0× 1.4k 0.9× 2.1k 1.9× 974 0.9× 323 0.4× 220 7.1k
Katsuhiko Okumura Japan 39 2.3k 0.9× 1.3k 0.8× 1.4k 1.3× 874 0.8× 311 0.3× 179 5.2k
Mikihisa Takano Japan 37 2.1k 0.8× 1.1k 0.7× 1.6k 1.5× 688 0.7× 414 0.5× 185 4.9k
Micheline Piquette‐Miller Canada 46 2.7k 1.0× 1.1k 0.7× 1.0k 1.0× 1.0k 1.0× 248 0.3× 128 5.3k
Gilbert J. Burckart United States 43 1.4k 0.5× 2.6k 1.7× 922 0.9× 932 0.9× 326 0.4× 255 7.4k
Manthena V. S. Varma United States 44 3.1k 1.1× 1.5k 1.0× 1.0k 1.0× 2.1k 2.0× 830 0.9× 127 5.7k
Yasufumi Sawada Japan 46 2.9k 1.1× 1.7k 1.1× 1.8k 1.7× 2.1k 2.0× 216 0.2× 362 7.7k
Robert Farinotti France 45 1.6k 0.6× 1.1k 0.7× 1.1k 1.0× 751 0.7× 246 0.3× 291 7.3k

Countries citing papers authored by Werner Siegmund

Since Specialization
Citations

This map shows the geographic impact of Werner Siegmund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Siegmund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Siegmund more than expected).

Fields of papers citing papers by Werner Siegmund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Werner Siegmund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Siegmund. The network helps show where Werner Siegmund may publish in the future.

Co-authorship network of co-authors of Werner Siegmund

This figure shows the co-authorship network connecting the top 25 collaborators of Werner Siegmund. A scholar is included among the top collaborators of Werner Siegmund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Werner Siegmund. Werner Siegmund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Böhm, Ruwen, Henrike Bruckmueller, Stefan Oswald, et al.. (2024). Phenotype–Genotype Correlation Applying a Cocktail Approach and an Exome Chip Analysis Reveals Further Variants Contributing to Variation of Drug Metabolism. Clinical Pharmacology & Therapeutics. 116(1). 204–216. 1 indexed citations
2.
Grube, Markus, et al.. (2023). Various effects of repeated rifampin dosing on coproporphyrin levels in humans. Clinical and Translational Science. 16(11). 2289–2298. 6 indexed citations
3.
Surur, Abdrrahman Shemsu, Lukas Schulig, Markus Kindermann, et al.. (2019). Flupirtine and retigabine as templates for ligand-based drug design of KV7.2/3 activators. Organic & Biomolecular Chemistry. 17(18). 4512–4522. 23 indexed citations
4.
Bruckmueller, Henrike, Paul Martin, Sierk Haenisch, et al.. (2017). Clinically Relevant Multidrug Transporters Are Regulated by microRNAs along the Human Intestine. Molecular Pharmaceutics. 14(7). 2245–2253. 29 indexed citations
5.
6.
Kühn, Jens‐Peter, Christiane Modeß, Eberhard Scheuch, et al.. (2017). Muscle Injury After Intramuscular Administration of Diclofenac: A Case Report Supported by Magnetic Resonance Imaging. PubMed. 4(1). 7–7. 6 indexed citations
7.
Oswald, Stefan, Ali Nassif, Christiane Modeß, et al.. (2011). Drug Interactions Between the Immunosuppressant Tacrolimus and the Cholesterol Absorption Inhibitor Ezetimibe in Healthy Volunteers. Clinical Pharmacology & Therapeutics. 89(4). 524–528. 11 indexed citations
8.
Turrini, Eleonora, et al.. (2010). Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function. The Pharmacogenomics Journal. 11(1). 25–34. 68 indexed citations
9.
Köck, Kathleen, Bernd Giese, Martin Fraunholz, et al.. (2010). Rapid Modulation of the Organic Anion Transporting Polypeptide 2B1 (OATP2B1, SLCO2B1) Function by Protein Kinase C-mediated Internalization. Journal of Biological Chemistry. 285(15). 11336–11347. 74 indexed citations
10.
May, Karen, et al.. (2010). Commonly used nonionic surfactants interact differently with the human efflux transporters ABCB1 (p-glycoprotein) and ABCC2 (MRP2). European Journal of Pharmaceutics and Biopharmaceutics. 76(2). 260–268. 82 indexed citations
11.
Venner, Monica, Markus Grube, Eberhard Scheuch, et al.. (2009). Concentration of the macrolide antibiotic tulathromycin in broncho-alveolar cells is influenced by comedication of rifampicin in foals. Naunyn-Schmiedeberg s Archives of Pharmacology. 381(2). 161–169. 36 indexed citations
12.
Schmiedl, Sven, Marietta Rottenkolber, Bernd Drewelow, et al.. (2007). Analysis of hospital admissions associated with digitalis glycosides. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 102(8). 603–611. 7 indexed citations
13.
Schmiedl, Sven, Marietta Rottenkolber, Bernd Drewelow, et al.. (2007). Fingerhut -ein alter Hut? : Eine Analyse stationärer Aufnahmen durch digitalisassoziierte unerwünschte Arzneimittelwirkungen. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 102(8). 603–611. 4 indexed citations
14.
Oswald, Stefan, et al.. (2006). Disposition and Sterol-Lowering Effect of Ezetimibe in Multidrug Resistance-Associated Protein 2-Deficient Rats. Journal of Pharmacology and Experimental Therapeutics. 318(3). 1293–1299. 28 indexed citations
15.
Gießmann, Thomas, Christiane Modeß, Danilo Wegner, et al.. (2006). Simvastatin does not influence the intestinal P‐glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms. British Journal of Clinical Pharmacology. 61(4). 440–450. 35 indexed citations
16.
Haenisch, Sierk, et al.. (2006). Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex. The Pharmacogenomics Journal. 7(1). 56–65. 118 indexed citations
17.
Gießmann, Thomas, Christiane Modeß, M Zschiesche, et al.. (2004). CYP2D6genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects. Clinical Pharmacology & Therapeutics. 75(3). 213–222. 110 indexed citations
18.
Fromm, Martin F., Hans-Martin Kauffmann, Péter Fritz, et al.. (2000). The Effect of Rifampin Treatment on Intestinal Expression of Human MRP Transporters. American Journal Of Pathology. 157(5). 1575–1580. 208 indexed citations
19.
Zschiesche, M, et al.. (1996). Debrisoquine 4‐hydroxylation and sulphamethazine N‐acetylation in patients with schizophrenia and major depression. British Journal of Clinical Pharmacology. 41(5). 428–431. 3 indexed citations
20.
Hoffmann, Christian, et al.. (1995). Comparative bioavailability of metronidazole formulations (Vagimid) after oral and vaginal administration.. PubMed. 33(4). 232–9. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pieter Annaert Breakdown of academic impact, for papers by Yusuke Tanigawara Breakdown of academic impact, for papers by Toshiyuki Sakaeda Breakdown of academic impact, for papers by Katsuhiko Okumura Breakdown of academic impact, for papers by Mikihisa Takano Breakdown of academic impact, for papers by Micheline Piquette‐Miller Breakdown of academic impact, for papers by Gilbert J. Burckart Breakdown of academic impact, for papers by Manthena V. S. Varma Breakdown of academic impact, for papers by Yasufumi Sawada Breakdown of academic impact, for papers by Robert Farinotti
Rankless by CCL
2026